ADMS - Adamas Pharma EPS beats by $0.10 misses on revenue May, 10 2021 04:13 PM Adamas Pharmaceuticals Inc. Adamas Pharma (ADMS): Q1 GAAP EPS of -$0.36 beats by $0.10.Revenue of $19.31M (+33.4% Y/Y) misses by $0.35M.Press Release For further details see: Adamas Pharma EPS beats by $0.10, misses on revenue